MENU
IBIO
AS OF
Dec 24 closing price
Price
$1.87
Change
-$0.01 (-0.53%)
Capitalization
42.05M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

iBio (IBIO) Ownership - Who owns iBio?

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.05M
P/E Ratio
0.65
Total Cash
49.57M
Projected Growth
N/A
Total Debt
3.28M
Revenue
500K
Risk (Beta)
2.91
Dividend Yield
N/A
Total Cash/Share
2.20
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

IBIO
Capitalization
42.1M
P/E Ratio
0.65
Risk (Beta)
2.91
Dividend Yield
N/A
Total Cash
49.6M
Total Cash/Share
2.20
Total Debt
3.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
500K
ROE
N/A
Book Value
56M
P/B Ratio
0.75
Cash Flow
N/A
Earnings
-1.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
8.39
Current Revenue Per Employee
5000.00
Dividends Per Share - Security
N/A
EBITDA
-18.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.41
Revenue To Assets
-45.35
Shares Held By Institutions
3.17M
Shares Outstanding - Current
22.5M
Total Liabilities
8.12M
Total Volume MTD
N/A
Value
1
Gain YTD
-23.673
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IBIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for IBIO
A.I. Advisor
published General Information

General Information

a company which engages in the development and commercialization of vaccines and therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A